Table 2:
Tumor Type (Pathologic Diagnosis) |
Diagnostic Performance | |||
---|---|---|---|---|
SCC | IP | |||
Model prediction for training dataset | ||||
SCC | 16 | 2 | Accuracy | 90.9%a |
Sensitivity | 94.1% | |||
IP | 1 | 14 | Specificity | 87.5% |
PPV | 88.9% | |||
Total | 17 | 16 | NPV | 93.3% |
Model prediction for validation dataset | ||||
SCC | 6 | 1 | Accuracy | 84.6%a |
Sensitivity | 85.7% | |||
IP | 1 | 5 | Specificity | 83.3% |
PPV | 85.7% | |||
Total | 7 | 6 | NPV | 83.3% |
Model prediction for entire cohort | ||||
SCC | 22 | 3 | Accuracy | 89.1% |
Sensitivity | 91.7% | |||
IP | 2 | 19 | Specificity | 86.4% |
PPV | 88.0% | |||
Total | 24 | 22 | NPV | 90.5% |
Note:—NPV indicates negative predictive value; PPV, positive predictive value.
With a 2-tailed test of population proportion, the accuracies for the training and validation datasets were not significantly different (P = .537).